Tianjin Zhongrui Parmaceutical Co., Ltd

Country/Region: China     State/Province: Tianjin

Main Products: Nicotinamide, Nicotinic Acid, Inositol Nictinate, Vitamin B3, Terazosin Hydrochlorid

Company Introduction
Tianjin Zhongrui Pharmaceutical Co., Ltd, which is a newly established large-scale comprehensive raw pharmaceutical manufacturer with advanced technology and facilities, is mainly engaged in the production and distribution of APIS. There are 158 of employees including 98 of college graduates, and 52 of techinicians of pharmacology and related disciplines, among which 12 are senior engineers, 20 are engineers and 6 are licensed pharmacists. The holding capital is RMB60 million.With advanced pharmaceutical manufacturing equipments and fine testing instruments, Tianjin Zhongrui Pharmaceutical Co., Ltd has established national GMP certified workshop and keeps a full quality assuarance system. We take a strict internal quality standards, which is better than those of domestic and international quality standards, to meet the demands of end customers.Our Orientation is to make Tianjin Zhongrui Pharmaceutical Co., Ltd a modern pharmaceutical manufacturer with the pull and core competitive capability of innovated technology and information, With modern management system, high performed team members, advanced technology, fine manufacturing equipments and testing instruments, and a full quality assurance system, Tianjin Zhongrui Pharmaceutical Co., Ltd is devoted to producing products of high quality to serve to the health of human living.
Company Overview

Business Type: Exporter, Services

Year Established: 1992

Employees: 5 - 10 People

Plant Area: 30,000-50,000 square meters

Contact Information

Fax: 86-22-29465809

Business Information

Main Markets: South America 11% Africa 10% Eastern Asia 11% Domestic Market 9% North America 11% Eastern Europe 11% Southern Europe 10% Mid East 12% Northern Europe 8% Oceania 7%

Trade Capacity: FOB, CFR, DES

Contract Manufacturing: OEM Service Offered

Nearest Port: Tianjin

Trade & Financial Information

Annual Revenue: US$1 Million - US$2.5 Million

Total Revenue: US$1 Million - US$2.5 Million

Export Revenue: Above US$100 Million

Annual Output: US$50 Million - US$100 Million

Registered Capital: US$1 Million - US$2.5 Million

Export Percentage: 91% - 100%

Payment Modes: USD, AUD, HKD

Lead Time: 21 days

Import/Export Mode: Have Own Export License

Product Showcase
nicotinamide
nicotinic acid
inositol nictinate
vitamin b3
terazosin hydrochlorid

CL-Link > Health & Medicines in China Health & Medicines in Tianjin Health Care Supplement in China Health Care Supplement in Tianjin